Skip to Main Content

And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is rather ambitious. We plan to indulge Mrs. Pharmalot as we turn another page in our journey together and hang with our short people, one of whom enjoys challenging us at the billiards table. And what about you? This is a fine time to catch up on some reading or make time for someone special. You could also start preparing your taxes or place bets on whether a certain government shuts down again soon. Well, whatever you do, have a grand time. But be safe. Enjoy, and see you soon …

The Trump administration proposed curbing the rebates that drug makers pay pharmacy benefit managers in Medicare in a bid to drive down the prices consumers pay for prescription medicines, STAT writes. Such rebates are currently not barred under statutes prohibiting kickbacks to win business with the federal government, but the new proposal could eliminate protection by potentially subjecting the rebates to review under anti-kickback statutes. The government hopes to redirect the rebates to Medicare beneficiaries and its proposal will take effect by Jan. 1.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!